Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

401.05INR
3:19pm IST
Price Change (% chg)

Rs4.15 (+1.05%)
Prev Close
Rs396.90
Open
Rs399.50
Day's High
Rs401.25
Day's Low
Rs394.60
Volume
1,051,745
Avg. Vol
1,590,767
52-wk High
Rs450.40
52-wk Low
Rs364.00

CIPL.NS

Chart for CIPL.NS

About

Cipla Limited is a pharmaceutical company. During the fiscal year ended March 31, 2012 (fiscal 2012), it introduced a number of new drugs and formulations, such as Adgain (vital nutritional supplement for hair loss); Capnea (caffeine citrate injection and oral solution) for apnoea of prematurity in infants; Caspogin (caspofungin... (more)

Overall

Beta: 0.24
Market Cap (Mil.): Rs318,679.50
Shares Outstanding (Mil.): 802.92
Dividend: 2.00
Yield (%): 0.50

Financials

  CIPL.NS Industry Sector
P/E (TTM): -- 32.56 32.65
EPS (TTM): -- -- --
ROI: -- 19.75 19.01
ROE: -- 20.45 19.78
Search Stocks

INDIA PRESS-Cipla may put patent for new HIV drug in open access pool-Mint

Note: Reuters has not verified this story and does not vouch for its accuracy. (Compiled by Abhiram Nandakumar in Bangalore)

11 Mar 2014

BSE Sensex ends down 255 points; Cipla shares plunge

MUMBAI - The BSE Sensex fell more than 1 percent on Thursday to post its biggest drop in one-and-a-half weeks as Cipla and Coal India slumped following disappointing earnings, while other blue chips tracked weaker global markets.

13 Feb 2014

Indian shares fall more than 1 pct; Cipla plunges

MUMBAI, Feb 13 - Indian shares fell more than 1 percent on Thursday to post their biggest drop in one-and-a-half weeks as Cipla and Coal India slumped following disappointing earnings, while other blue chips tracked weaker global markets.

13 Feb 2014

Cipla shares fall as margin worries prompt downgrades

MUMBAI - Cipla Ltd shares fell on Thursday to their lowest in a month, as worries about high costs on the drugmaker's profit margins triggered a stock rating downgrade by some brokerages.

13 Feb 2014

Indian shares fall 1.3 pct; Cipla slumps

MUMBAI, Feb 13 - Indian shares fell more than 1 percent on Thursday to post their second-biggest drop this month as Cipla and Coal India slumped following disappointing earnings, while other blue chips tracked their lower global counterparts.

13 Feb 2014

India's Cipla shares fall as margin worries prompt downgrades

MUMBAI, Feb 13 - India's Cipla Ltd shares fell as much as 7 percent on Thursday to their lowest in a month, as worries about high costs on the drugmaker's profit margins triggered a stock rating downgrade by some brokerages.

13 Feb 2014

MARKET EYE-Indian shares lower; Cipla, Coal India fall after earnings

* India's benchmark BSE index falls 0.46 percent, while the broader NSE index is down 0.55 percent. * Shares of Cipla fall as much as 6.02 percent after the company's December-quarter profit dropped by 16.5 percent to 2.84 billion rupees, lagging some analysts' estimates. * Coal India Ltd, the world's largest coal miner by output, is trading 2.15 percent lower after its December quarter earnings fell short of expectations. * Overseas investors bought Indian shares worth 2.12 billion rupees ($

13 Feb 2014

India's Cipla slumps after December-quarter earnings lag estimates

MUMBAI, Feb 13 - Shares in India's Cipla Ltd fell 5.5 percent in pre-open trade after company's December quarter profit fell by 16.5 percent to 2.84 billion rupees, lagging some analysts estimates.

13 Feb 2014

Cipla hikes stake in Quality Chemical to 51.05 percent for $15 million

Cipla, through its wholly-owned subsidiary Meditab Holdings Ltd (MHL), has acquired an additional 14.5 per cent stake in Quality Chemical Industries Ltd (QCIL), Uganda, for $15 million, as per a stock market disclosure.

22 Nov 2013

BRIEF-India's Cipla says subsidiary buys stake in Quality Chemical for $15 mln

Nov 21 - Cipla Ltd : * Says subsidiary of co has acquired additional 14.5 percent stake in quality

21 Nov 2013

Earnings vs. Estimates

Search Stocks